Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11
Phase 21

Trial Status

Completed2

Role Distribution

Other Roles2

Activity Timeline

Clinical Trials (2)

NCT02503332Phase 2Completed
Study of Pegcetacoplan (APL-2) Therapy in Patients With Geographic Atrophy
Geographic Atrophy
StudydirectorStart date: 2015-09-24
NCT02461771Phase 1Completed
Assessment of Safety, Tolerability and Pharmacokinetics of Intravitreal Pegcetacoplan (APL-2) for Patients With Wet AMD
Neovascular Age-Related Macular Degeneration
StudydirectorStart date: 2015-01-28

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Apellis Pharmaceuticals, Inc.

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT02503332Phase 2StudyDirector

Study of Pegcetacoplan (APL-2) Therapy in Patients With Geographic Atrophy

Geographic Atrophy
Completed
NCT02461771Phase 1StudyDirector

Assessment of Safety, Tolerability and Pharmacokinetics of Intravitreal Pegcetacoplan (APL-2) for Patients With Wet AMD

Neovascular Age-Related Macular Degeneration
Completed

All 2 trials loaded